Advertisement
Screener

Apyx Medical Corp (APYX) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

2.8 / 5 stars · 68/120 Roast Me

Apyx Medical Corp Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

Apyx Medical Corp (APYX) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-03-10

  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2023-03-31 was 0.00%.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2022-03-31 was 0.00%.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
  • Apyx Medical Corp share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2025-12-310.00%
10-K · filed 2026-03-10
2025-09-300.00%
10-Q · filed 2025-11-06
2025-06-300.00%
10-Q · filed 2025-08-07
2025-03-310.00%
10-Q · filed 2025-05-08
2024-12-310.00%
10-K · filed 2026-03-10
2024-09-300.00%
10-Q · filed 2024-11-08
2024-06-300.00%
10-Q · filed 2024-08-08
2024-03-310.00%
10-Q · filed 2024-05-09
2023-12-310.00%
10-K · filed 2025-03-13
2023-09-300.00%
10-Q · filed 2023-11-09
2023-06-300.00%
10-Q · filed 2023-08-11
2023-03-310.00%
10-Q · filed 2023-05-11
2022-12-310.00%
10-K · filed 2024-03-21
2022-09-300.00%
10-Q · filed 2022-11-10
2022-06-300.00%
10-Q · filed 2022-08-11
2022-03-310.00%
10-Q · filed 2022-05-12
2021-12-310.00%
10-K · filed 2023-03-16
2021-09-300.00%
10-Q · filed 2021-11-12
2021-06-300.00%
10-Q · filed 2021-08-12
2021-03-310.00%
10-Q · filed 2021-05-12
2020-12-310.00%
10-K · filed 2022-03-17
2020-09-300.00%
10-Q · filed 2020-11-09
2020-06-300.00%
10-Q · filed 2020-08-10
2020-03-310.00%
10-Q · filed 2020-05-11
2019-12-310.00%
10-K · filed 2021-03-31
2019-09-300.00%
10-Q · filed 2019-11-15
2019-06-300.00%
10-Q · filed 2019-08-07
2019-03-310.00%
10-Q/A · filed 2020-05-08
2018-12-310.00%
10-K · filed 2020-03-31
2018-09-300.00%
10-Q/A · filed 2020-05-08
2018-06-300.00%
10-Q · filed 2018-08-01
2018-03-310.00%
10-Q · filed 2018-05-15
2017-12-310.00%
10-K · filed 2020-03-31
2017-09-300.00%
10-Q · filed 2017-11-03
2017-06-300.00%
10-Q · filed 2017-08-03
2017-03-310.00%
10-Q · filed 2017-05-15
2016-12-310.00%
10-K · filed 2019-03-14
2016-09-300.00%
10-Q · filed 2016-10-27
2016-06-300.00%
10-Q · filed 2016-08-02
2016-03-310.00%
10-Q · filed 2016-05-11
2015-12-310.00%
10-K · filed 2018-03-13
2015-09-300.00%
10-Q · filed 2015-11-05
2015-06-300.00%
10-Q · filed 2015-08-07
2015-03-310.00%
10-Q · filed 2015-05-08
2014-12-310.00%
10-K · filed 2017-03-10
2014-09-300.00%
10-Q · filed 2014-11-10
2014-06-300.00%
10-Q · filed 2014-08-08
2014-03-310.00%
10-Q · filed 2014-05-15
2013-12-310.00%
10-K/A · filed 2014-05-08
2013-09-300.00%
10-Q · filed 2013-11-14
2013-06-300.00%
10-Q/A · filed 2013-09-25
2013-03-310.00%
10-Q · filed 2013-05-15
2012-12-310.00%
10-K/A · filed 2014-05-08
2012-09-300.00%
10-Q · filed 2012-11-14
2012-06-300.00%
10-Q · filed 2012-08-14
2011-12-310.00%
10-K/A · filed 2014-05-08
2010-12-310.00%
10-K · filed 2013-04-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Microbot Medical Inc. (MBOT)$0.089B-7.97
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
LENSAR, Inc. (LNSR)United States$0.087B2.02
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
Pulmonx Corp (LUNG)United States$0.082B-1.16
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
Lucid Diagnostics Inc. (LUCD)United States$0.170B
CVRx, Inc. (CVRX)United States$0.067B-2.62
DarioHealth Corp. (DRIO)$0.066B-1.39